UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

A Comprehensive Approach to the Recognition, Diagnosis, and Severity‐Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee

Dermatologic surgery, 2007-08, Vol.33 (8), p.908-923

2007

Link zum Volltext

Verfügbarkeit prüfen

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Journal of cutaneous medicine and surgery, 2011-07, Vol.15 (4), p.210-219

2011

Link zum Volltext

Verfügbarkeit prüfen

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris

Journal of the American Academy of Dermatology, 2007-03, Vol.56 (3), p.439.e1-439.e10

2007

Link zum Volltext

Verfügbarkeit prüfen

The Burden of Psoriasis in Canada: Insights from the pSoriasis Knowledge IN Canada (SKIN) Survey

Journal of cutaneous medicine and surgery, 2009-09, Vol.13 (5), p.235-252

2009

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole

Pediatric dermatology, 2001-10, Vol.18 (5), p.433-438

2001

Link zum Volltext

Verfügbarkeit prüfen

Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Journal of cutaneous medicine and surgery, 2005-12, Vol.9 (S1), p.1-3

LYNDE, Charles

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of Biologic Therapeutics in Difficult-to-Treat Psoriasis

Journal of cutaneous medicine and surgery, 2009-01, Vol.13 (1), p.6-17

Lynde, Charles

2009

Link zum Volltext

Verfügbarkeit prüfen

Position Statement for Isotretinoin

Journal of cutaneous medicine and surgery, 2007-05, Vol.11 (3), p.123-124

2007

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face

Journal of cutaneous medicine and surgery, 2003-01, Vol.7 (1), p.31-37

2003

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Comprehensive Acne Severity Scale

Journal of cutaneous medicine and surgery, 2007-11, Vol.11 (6), p.211-216

2007

Link zum Volltext

Verfügbarkeit prüfen

Canadian Hand Dermatitis Management Guidelines

Journal of cutaneous medicine and surgery, 2010-11, Vol.14 (6), p.267-284

2010

Link zum Volltext

Verfügbarkeit prüfen

Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne

Journal of cutaneous medicine and surgery, 2008-09, Vol.12 (5), p.235-242

2008

Link zum Volltext

Verfügbarkeit prüfen

Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis

Journal of cutaneous medicine and surgery, 1998-01, Vol.2 (3), p.142

1998

Link zum Volltext

Verfügbarkeit prüfen

Onychomycosis in children: Prevalence and treatment strategies

Journal of the American Academy of Dermatology, 1997-03, Vol.36 (3), p.395-402

1997

Link zum Volltext

Verfügbarkeit prüfen

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

Journal of Cutaneous Medicine and Surgery, 2011-11, Vol.15 (6), p.309-321

2011

Link zum Volltext

Verfügbarkeit prüfen

Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis

Journal of cutaneous medicine and surgery, 2012-03, Vol.16 (1_suppl), p.S1-S15

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment

Journal of cutaneous medicine and surgery, 2009-07, Vol.13 (4), p.204-208

2009

Link zum Volltext

Verfügbarkeit prüfen

Use of pimecrolimus cream 1% (Elidel®) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome

International journal of dermatology, 2005-01, Vol.44 (1), p.70-75

2005

Link zum Volltext

Verfügbarkeit prüfen

Practical considerations for the initiation and maintenance of etanercept in the treatment of psoriasis: Etanercept: a novel TNF antagonist for the treatment of psoriatic disease

Journal of cutaneous medicine and surgery, 2007, Vol.11

2007

Link zum Volltext

Verfügbarkeit prüfen

Integrating biologic agents into management of moderate-to-severe psoriasis: A consensus of the Canadian psoriasis expert panel

Journal of cutaneous medicine and surgery, 2004-10, Vol.8 (5), p.321-337

2004

Link zum Volltext

Verfügbarkeit prüfen

The AWARE Study: Methodology and Baseline Characteristics: Amevive Wisdom Acquired from Real-World Evidence

Journal of cutaneous medicine and surgery, 2009, Vol.13

2009

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis : individualized patient approaches: Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Journal of cutaneous medicine and surgery, 2005, Vol.9, p.18-25

2005

Link zum Volltext

Verfügbarkeit prüfen

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis: Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Journal of cutaneous medicine and surgery, 2005, Vol.9, p.26-32

2005

Link zum Volltext

Verfügbarkeit prüfen

Onychomycosis : predisposed populations and some predictors of suboptimal response to oral antifungal agents

EJD. European journal of dermatology, 1999-12, Vol.9 (8), p.633-638

1999

Link zum Volltext

Verfügbarkeit prüfen

The use of alefacept in the treatment of psoriasis: Approaches to the use of biologic therapy in the management of psoriasis

Journal of cutaneous medicine and surgery, 2004, Vol.8, p.14-18

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(30)
Dermatology
(28)
Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Psoriasis. Parapsoriasis. Lichen
(12)
Female
(9)
Male
(8)
Treatment Outcome
(8)
Canada
(7)
Skin Involvement In Other Diseases. Miscellaneous. General Aspects
(7)
Adult
(6)
Adolescent
(5)
Dermatologic Agents - Therapeutic Use
(5)
Psoriasis
(5)
Quality Of Life
(5)
Acne Vulgaris - Pathology
(4)
Child
(4)
Double-Blind Method
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Comprehensive Approach to the Recognition, Diagnosis, and Severity‐Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris

The Burden of Psoriasis in Canada: Insights from the pSoriasis Knowledge IN Canada (SKIN) Survey

Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole

Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Use of Biologic Therapeutics in Difficult-to-Treat Psoriasis

Position Statement for Isotretinoin

A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face

Development and Validation of a Comprehensive Acne Severity Scale

Canadian Hand Dermatitis Management Guidelines

Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne

Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis

Onychomycosis in children: Prevalence and treatment strategies

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis

Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment

Use of pimecrolimus cream 1% (Elidel®) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome

Practical considerations for the initiation and maintenance of etanercept in the treatment of psoriasis: Etanercept: a novel TNF antagonist for the treatment of psoriatic disease

Integrating biologic agents into management of moderate-to-severe psoriasis: A consensus of the Canadian psoriasis expert panel

The AWARE Study: Methodology and Baseline Characteristics: Amevive Wisdom Acquired from Real-World Evidence

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis : individualized patient approaches: Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis: Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

Onychomycosis : predisposed populations and some predictors of suboptimal response to oral antifungal agents

The use of alefacept in the treatment of psoriasis: Approaches to the use of biologic therapy in the management of psoriasis

Aktive Filter

Suchergebnisse filtern